American Vanguard Corporation (AVD) Market Cap
American Vanguard Corporation has a market capitalization of $68.4M.
Price: $2.39
▼ -0.07 (-2.85%)
Market Cap: 68.37M
NYSE · time unavailable
CEO: Douglas A. Kaye
Sector: Basic Materials
Industry: Agricultural Inputs
IPO Date: 1987-03-03
Website: https://www.american-vanguard.com
American Vanguard Corporation (AVD) - Company Information
Market Cap: 68.37M|Sector: Basic Materials
Company Profile
American Vanguard Corporation, through its various subsidiaries, develops, manufactures, and markets a diverse portfolio of specialized chemicals for agricultural, commercial, and consumer applications across the United States and internationally. The company formulates and produces a comprehensive range of chemicals, including pest control agents like insecticides, fungicides, herbicides, and molluscicides, as well as solutions for soil health, plant nutrition, growth regulation, and soil fumigation. These offerings are available in liquid, powder, and granular forms, serving purposes in crop cultivation, turf and ornamental plant management, and human and animal health protection. American Vanguard also actively promotes, sells, and distributes finished chemical and biological products specifically designed for crop uses, and extends its distribution services to chemicals for the turf and ornamental markets. Its extensive distribution network encompasses partnerships with national distribution firms, purchasing collectives, and co-operatives, alongside its own sales offices, dedicated sales force, independent sales agents, and fully owned distribution entities. Established in 1969, the company maintains its corporate headquarters in Newport Beach, California.
Analyst Sentiment
From 1 Active Polls
1Y Forecast: $17.00
▲ +611.3% Potential Upside
Consensus Target Metrics
Low Bound
$14
Median
$17
High Bound
$20
Average
$17
Price & Moving Averages
🎯 Wall Street Analyst Intelligence Report
1-Year structural target targets, chart projections, and sentiment maps.
Consensus Trend Projection
Trailing closures vs. 12-month metrics map.
Analyst Vote Distribution
Aggregate institutional coverage sentiment weights.
📊 Historical Valuation Multiples
Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.
| Fiscal Quarter | TTM | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Trailing 12M | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
| Market Cap ($M) | 68 | 71 | 111 | 164 | 111 | 124 | 130 | 149 | 236 |
| Enterprise Value ($M) | 281 | 284 | 290 | 347 | 305 | 299 | 286 | 338 | 453 |
| Price to Earnings Ratio (P/E) | -1.52 | -4.45 | -0.98 | -3.34 | -32.67 | -3.67 | -0.36 | -1.46 | -5.02 |
| Price/Earnings-to-Growth Ratio (PEG) | — | — | -0.04 | — | -2.80 | — | -0.01 | — | — |
| Price to Sales Ratio (P/S) | 0.13 | 0.58 | 0.74 | 1.37 | 0.86 | 1.07 | 0.79 | 1.26 | 1.84 |
| Price to Book Ratio (P/B) | 0.36 | 0.38 | 0.58 | 0.74 | 0.48 | 0.55 | 0.56 | 0.46 | 0.67 |
| Price to Free Cash Flow Ratio (P/FCF) | -1.68 | -1.96 | 25.17 | 14.53 | -5.60 | -5.91 | 4.01 | 5.59 | -14.64 |
| Enterprise Value to Sales (EV/Sales) | — | 2.29 | 1.92 | 2.91 | 2.36 | 2.58 | 1.72 | 2.86 | 3.53 |
| Enterprise Value to EBITDA (EV/EBITDA) | -44.92 | 49.38 | -16.38 | -114.40 | 34.94 | 1495.73 | -25.20 | -14.94 | -115.21 |
| Debt to Equity Ratio | -33.97 | 1.49 | 0.99 | 0.91 | 0.90 | 0.82 | 0.72 | 0.61 | 0.66 |
📰 Market News & Coverage
15 Stories AvailableReal-time institutional reporting and market updates for AVD.
American Vanguard Corporation (AVD) Announces Executive Appointment of Hermann Castro as Senior Vice President, Marketing and Business Development at AMVAC
NEWPORT BEACH, CA / ACCESS Newswire / July 1, 2026 / American Vanguard Corporation (NYSE:AVD) today announced that Hermann Castro has joined its executive team as Senior Vice President, Marketing and Business Development. Mr. Castro brings more than 25 years of global leadership experience across the agricultural value chain, including crop protection, seed and traits, production agriculture, and fresh produce systems.
American Vanguard Announces Voting Results Of 2026 Annual Meeting Of Stockholders
NEWPORT BEACH, CA / ACCESS Newswire / June 8, 2026 / American Vanguard Corporation (NYSE:AVD) announced the voting results from its Annual Meeting of Stockholders held on June 3, 2026. As to the first of four initiatives, the seven director nominees named in the proxy received more votes "for" than "against"; those persons are: Marisol Angelini, Mark Bassett, Patrick Gottschalk, Douglas Kaye, Steven Macicek, Rubin McDougal and Keith Rosenbloom.
Bristol Myers Squibb Announces Opdivo® (nivolumab) in Combination with AVD Receives Expanded EU Label with Approval in Frontline Advanced Classical Hodgkin Lymphoma
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #HodgkinLymphoma--BMS Announces Opdivo (nivolumab) in Combination with AVD Receives Expanded EU Label with Approval in Frontline Advanced Classical Hodgkin Lymphoma.
American Vanguard Corporation (AVD) Q1 2026 Earnings Call Transcript
American Vanguard Corporation (AVD) Q1 2026 Earnings Call Transcript
American Vanguard Reports First Quarter 2026 Results
First Quarter Revenue Growth of 7% to $124 million Gross Margin Expansion of 500 bps Reaffirm Full-Year Outlook; Adjusted EBITDA $44 million to $48 million on Sales of $530 million to $550 million NEWPORT BEACH, CA / ACCESS Newswire / May 6, 2026 / American Vanguard Corporation, a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and nutrition, turf and ornamental management and commercial pest control, today reported financial results for the first quarter ended March 31, 2026. Financial and Operational Highlights First Quarter 2026 - versus First Quarter 2025: Net sales of $124 million vs.
American Vanguard Announces Date of First Quarter 2026 Earnings Release and Webcast Conference Call
NEWPORT BEACH, CA / ACCESS Newswire / May 4, 2026 / American Vanguard Corporation announced today that it will report financial results for the quarter ended March 31, 2026, on Wednesday, May 6, 2026, after the market closes. In addition, the company will conduct an earnings conference call on that day at 4:30 pm ET/ 1:30 pm PT. CEO Dak Kaye and CFO David Johnson will host the event.
Green Plains (NASDAQ:GPRE) & American Vanguard (NYSE:AVD) Financial Survey
Green Plains (NASDAQ: GPRE - Get Free Report) and American Vanguard (NYSE: AVD - Get Free Report) are both small-cap basic materials companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, institutional ownership, dividends, valuation and risk. Risk and Volatility Green Plains has
Contrasting American Vanguard (NYSE:AVD) and Huabao International (OTCMKTS:HUIHY)
Huabao International (OTCMKTS:HUIHY - Get Free Report) and American Vanguard (NYSE: AVD - Get Free Report) are both small-cap basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership and profitability. Profitability This table compares Huabao International
Financial Comparison: International Flavors & Fragrances (NYSE:IFF) and American Vanguard (NYSE:AVD)
American Vanguard (NYSE: AVD - Get Free Report) and International Flavors and Fragrances (NYSE: IFF - Get Free Report) are both basic materials companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, risk, dividends, analyst recommendations, earnings and valuation. Profitability This table compares American
American Vanguard Corporation (AVD) Q4 2025 Earnings Call Transcript
American Vanguard Corporation (AVD) Q4 2025 Earnings Call Transcript
American Vanguard Announces Date of Full Year 2025 Earnings Release and Webcast Conference Call
NEWPORT BEACH, CA / ACCESS Newswire / March 13, 2026 / American Vanguard® Company announced today that it will report financial results for the full year ending December 31, 2025, on Monday, March 16, after the market closes. The company will conduct an earnings conference call on that day at 4:30 pm ET/ 1:30 pm PT.
American Vanguard (AVD) Expected to Announce Earnings on Wednesday
American Vanguard (NYSE: AVD - Get Free Report) is expected to announce its Q4 2025 results before the market opens on Wednesday, March 11th. Analysts expect the company to announce earnings of $0.28 per share and revenue of $163.00 million for the quarter. Individuals can find conference call details on the company's upcoming Q4 2025 earning
American Vanguard (NYSE:AVD) Stock Price Crosses Above 200-Day Moving Average – Time to Sell?
Shares of American Vanguard Corporation (NYSE: AVD - Get Free Report) passed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $4.85 and traded as high as $5.35. American Vanguard shares last traded at $5.2440, with a volume of 134,157 shares changing hands. Analysts Set New Price
American Vanguard Corporation Announces Executive Appointment and Relocation of Global Headquarters
NEWPORT BEACH, CA / ACCESS Newswire / January 14, 2026 / American Vanguard Corporation (NYSE:AVD) has announced, the following change to its executive management team. Mike DiPaola has been appointed Chief Commercial Officer.
Reviewing Mativ (NYSE:MATV) and American Vanguard (NYSE:AVD)
Mativ (NYSE: MATV - Get Free Report) and American Vanguard (NYSE: AVD - Get Free Report) are both small-cap basic materials companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, earnings, dividends and risk. Volatility and Risk Mativ has a beta
Related Companies in Basic Materials
TRINSEO PLC (TSE)
Basic Materials
$0.00B
Mkt Cap
ASCENT INDUSTRIES (ACNT)
Basic Materials
$0.14B
Mkt Cap
SMITH MIDLAND CORP (SMID)
Basic Materials
$0.14B
Mkt Cap
CONTANGO ORE INC (CTGO)
Basic Materials
$0.19B
Mkt Cap
CORE MOLDING TECHNOLOGIES INC (CMT)
Basic Materials
$0.21B
Mkt Cap
US GOLD CORP (USAU)
Basic Materials
$0.21B
Mkt Cap
📊 AI Financial Analysis
Powered by StockMarketInfo"AVD reported Q1’26 revenue of $123.6M and net income of -$4.1M (EPS -$0.14). Revenue rose 6.7% QoQ ($115.8M in Q1’25 is not comparable QoQ, so QoQ comparison uses Q4’25), and was -17.9% YoY vs Q1’25 revenue of $115.8M? (YoY revenue change: +6.7% vs 2025-03-31 $115.8M; QoQ revenue change: -17.9% vs 2025-12-31 $150.7M). Net income improved sharply QoQ (from -$28.2M in Q4’25 to -$4.1M in Q1’26), but remained loss-making and was better YoY (-$8.5M in Q1’25 to -$4.1M in Q1’26). Gross margin improved sequentially (31.1% in Q1’26 vs 26.2% in Q4’25) and slightly declined YoY (31.1% vs 26.1% in Q1’25). Operating income of $1.9M flipped positive after a weak prior quarter (operating income +$1.9M vs +$6.0M in Q4’25; still below the profitability peak was earlier). Cash flow was a key swing factor: operating cash flow was -$35.4M in Q1’26, but cash balances increased to $70.9M, supported by financing inflows (+$95.0M). Total shareholder returns are weak: the stock is at $2.64 with -30.5% 1Y change and no dividend yield shown. Overall, the quarter shows improving profitability versus the prior quarter but unstable cash generation and continued losses."
Revenue Growth
QoQ revenue declined -18.0% (Q4’25 $150.7M → Q1’26 $123.6M) while YoY revenue increased +6.7% (Q1’25 $115.8M → Q1’26 $123.6M).
Profitability
Margins improved sequentially: gross margin expanded to 31.1% from 26.2% QoQ, and net loss narrowed to -3.4% from -18.7% QoQ. Net income improved QoQ (-$28.2M → -$4.1M) and YoY (-$8.5M → -$4.1M), with EPS at -$0.14.
Cash Flow Quality
Operating cash flow deteriorated to -$35.4M in Q1’26 vs +$5.95M in Q4’25. Despite that, cash increased (+$58.5M) due to financing inflows; no dividends were paid and buybacks were minimal.
Leverage & Balance Sheet
Balance sheet resilience improved: cash rose to $70.9M and net debt turned negative (-$52.2M net debt) from strongly positive in prior quarters. Total assets increased to $665.2M from $596.5M, and equity was stable at $189.6M.
Shareholder Returns
No dividend yield shown and 1Y price performance is weak (-30.53%). There is no indication of a >20% 1-year momentum tailwind.
Analyst Sentiment & Valuation
Street target consensus is $17 (high $20 / low $14) vs current price $2.64, implying significant upside. Valuation indicators appear optically depressed given losses, but the target suggests bullish sentiment.
Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.
Fundamentals Overview
AVD delivered a strong Q1 performance with net sales of $124M (+7% YoY) and an outsized adjusted EBITDA jump to $10.3M (+245% YoY). The key driver was operating leverage and mix: gross margin expanded 500 bps to 31%, supported by higher-margin U.S. crop/specialty volumes and improved factory efficiency, while adjusted operating expenses improved 120 bps to 26.7% of sales. Growth was largely domestic—U.S. crop sales rose 17% on herbicide/insecticide demand, while specialty added 6% via OHP horticulture and biological solutions. International declined 7% mainly due to delivery timing in Brazil and delayed customer purchasing in India, partially offset by Central America’s Mocap launch in Ecuador. Balance sheet momentum improved cash to $71M post-refinancing, though net debt increased to ~$196M due to lower end-2025 customer prepayments. Management reiterated 2026 guidance (sales $530M-$550M; EBITDA $44M-$48M) and targets: long-term ~15% EBITDA margins, near-term double-digit margins, and net-debt paydown over 2–2.5 years.
Growth Catalysts
- U.S. crop sales +17% driven by strong demand for herbicide and insecticide products
- Specialty segment sales +6% driven primarily by OHP horticultural performance and increased demand for biological solutions
- Central America growth supported by the launch of Mocap in Ecuador
Business Development
- Launch of Mocap in Ecuador (Central America) contributing to improved regional sales
- Ongoing strategic engagement to defend Folex market share against generics (market-share growth objective within a specific product segment)
Financial Highlights
- Net sales $124M, +7% YoY; U.S. crop +17% while international revenue -7% YoY
- Adjusted EBITDA $10.3M vs $3.0M prior year, +245% YoY (increase of $7.3M)
- Gross margin expanded to 31% from 26%: +500 bps YoY
- Adjusted operating expenses (ex-transformation/impairment items) were 26.7% of sales vs 27.9% in Q1 2025 (improvement of 120 bps)
- Cash on hand increased to $71M from $12M year-ago due to refinancing replacing revolver with term loan structure
- Total debt $267M vs $166M year-ago; net debt ~ $196M vs $154M year-ago, primarily due to lower customer prepayments at end of 2025
- Inventories $175M vs $185M year-ago (-$10M), reflecting supply-chain discipline and SIOP planning improvements
Capital Funding
- Refinancing: term loans replaced revolver (working-capital facility) to better align with long-term strategy
- Planned net-debt paydown over 2 to 2.5 years with eventual refinancing considered by end of 2028
- Debt level at quarter end: $267M; cash at quarter end: $71M; net debt ~ $196M
- Net working capital improvement expected to supplement cash flow and support debt reduction
Strategy & Ops
- Manufacturing footprint rationalization: transfer production from focused L.A. facility to Axis, Alabama, driving efficiency and cost savings
- Annualized savings from L.A. rationalization: at least $4M
- Relocating headquarters in May 2026 to reduce operating costs and align responsibilities/accountability
- Technology footprint as a top priority: aim for seamless, connected systems to improve execution and responsiveness
- New product development cadence goal: 50 new product launches over 5 years targeting $100M annualized revenue by 2030; fruits of change expected to be visible more by 2028
Market Outlook
- 2026 guidance: adjusted EBITDA $44M to $48M on sales $530M to $550M
- Industry backdrop expectation: agricultural industry growth likely single digits in 2026 (not negative)
- Management targets: long-term ~15% EBITDA margins across the cycle; short-term prioritize moving to double-digit EBITDA margins as soon as possible; revenue target north of $600M annualized (about 20% above 2025) over time
Risks & Headwinds
- Distributor behavior: no inclination to restock inventories despite worst destocking appearing past
- Farmer liquidity remains a top concern, driving last-minute crop decisions
- Geopolitical uncertainty and commodity/inputs volatility (higher oil, natural gas, fertilizer); fertilizer impact expected to show more on next year's crop decisions
- International headwinds: Q1 decline driven by delivery timing in Brazil and reduced India sales due to timing delays in customer purchases
- Generics pressure: coming into the marketplace heavily; Folex generics pressure not yet impacting 2026 sales but risk remains (special strategic response to defend share)
Q&A: Analyst Interest
- Topic: Price vs volume drivers of the +7% top-line growth. Management attributed the U.S. increase primarily to volume (not pricing), emphasized improving internal data quality, and suggested the international weakness reflected shipment timing/comparables rather than demand collapse, with volume as the dominant U.S. lever.
- Topic: Generics impact and how it affects 2026 pricing and product performance. Management said generics are entering heavily, but branded products are relatively “sticky.” They noted Folex generic pressure has not yet impacted 2026 sales (not in the cycle), and they are actively working to defend market share and grow share.
- Topic: Crop-specific demand drivers behind the 17% U.S. increase and whether it is timing/comps. Management cited Impact and Aztec as the two large products showing increases, noted Impact/Aztec were down in Q4 2025 and up in Q1 2026, and said Metam was flat/slightly down after Q4 weakness; they emphasized timing dynamics.
Sentiment: MIXED
Note: This summary was synthesized by AI from the AVD Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.
📋 Official Regulatory 10-K / 10-Q SEC Filings
Direct authenticated documentation links to audited SEC database reports for AVD.